The Urology Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Instruments, Consumables & Accessories), By Application (Kidney failure treatment devices, UI management devices, BPH treatment devices, Urolithiasis treatment devices, Others), By End-User (Hospitals, ASCS, Dialysis Centers, Others).
Urology devices encompass a wide range of medical tools and equipment used in the diagnosis, treatment, and management of disorders affecting the urinary tract and male reproductive system. In 2024, advancements in urology devices continue to revolutionize patient care, offering minimally invasive procedures, improved precision, and enhanced patient outcomes. From catheters and stents to lithotripters and robotic surgical systems, these devices play a pivotal role in addressing conditions such as kidney stones, urinary incontinence, benign prostatic hyperplasia (BPH), and urological cancers. With a growing aging population and rising awareness of urological health, the demand for innovative urology devices is expected to soar, driving research and development efforts to meet evolving clinical needs.
A prominent trend in the urology devices market is the integration of robotics and artificial intelligence (AI) technologies to enhance surgical precision, improve outcomes, and optimize patient care in urological procedures. Robotics-assisted surgical systems, such as robotic-assisted laparoscopic surgery (RALS) platforms, offer urologists greater dexterity, visualization, and control during minimally invasive procedures such as prostatectomy, nephrectomy, and cystectomy. Additionally, AI algorithms are being employed to analyze medical imaging data, predict patient outcomes, and assist in surgical decision-making, leading to more personalized and efficient treatment approaches. As healthcare providers embrace the benefits of robotic and AI technologies in urology, there is a growing demand for innovative urological devices that integrate these advanced capabilities, driving market growth and fostering innovation in the field of robotic-assisted and AI-enabled urological interventions.
A key driver propelling the growth of the urology devices market is the aging population and the consequent rise in the prevalence of urological disorders and conditions such as urinary incontinence, benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), kidney stones, and urologic cancers. With demographic shifts leading to a larger elderly population globally, there is a corresponding increase in the demand for urological treatments and interventions to manage age-related urological issues and comorbidities. Additionally, lifestyle factors such as sedentary lifestyles, obesity, and dietary habits contribute to the prevalence of urological disorders, further driving the need for urology devices and interventions. Healthcare providers are investing in advanced urological devices and technologies to meet the growing demand for effective diagnosis, treatment, and management of urological conditions, fueling market growth and innovation in the urology devices sector.
An emerging opportunity in the urology devices market lies in the development of minimally invasive and disposable urological devices that offer enhanced safety, patient comfort, and cost-effectiveness in urological procedures. Minimally invasive techniques, such as laparoscopic and endoscopic procedures, are increasingly preferred over traditional open surgeries due to their reduced post-operative pain, shorter recovery times, and lower risk of complications. There is potential for manufacturers to innovate disposable urology devices such as ureteroscopes, cystoscopes, and biopsy forceps, designed for single-use applications to reduce the risk of cross-contamination, improve infection control, and streamline workflow in urology clinics and operating rooms. Additionally, there is an opportunity to develop minimally invasive devices for emerging urological procedures, such as percutaneous nephrolithotomy (PCNL) for kidney stone removal or transurethral prostate microwave thermotherapy (TUMT) for BPH treatment, to address unmet clinical needs and expand market reach. By focusing on the development of minimally invasive and disposable urology devices, manufacturers can capitalize on this opportunity, differentiate their offerings, and contribute to improved patient outcomes and healthcare efficiency in urology practice.
Among the segments within the Urology Devices Market, the category of Laser & Lithotripsy Devices emerges as the fastest growing, propelled by several key factors. Laser & Lithotripsy Devices are integral to the management of urolithiasis, a common condition characterized by the formation of urinary stones in the kidneys, bladder, or urinary tract. The rising prevalence of urolithiasis worldwide, attributed to factors such as dietary habits, sedentary lifestyles, and increasing incidence of metabolic disorders, drives the demand for effective treatment modalities. Laser & Lithotripsy Devices offer minimally invasive and highly efficient solutions for fragmenting urinary stones, thereby facilitating their removal through natural urinary pathways. The technological advancements in laser systems, including the development of more precise and versatile devices with enhanced safety profiles, contribute to their growing adoption in urological procedures. Additionally, the increasing preference for outpatient and minimally invasive procedures, driven by factors such as shorter recovery times, reduced hospital stays, and improved patient outcomes, further stimulates the demand for Laser & Lithotripsy Devices. Hospitals, ambulatory surgical centers (ASCs), and specialized urology clinics constitute the primary end-users of these devices, reflecting the broad scope of applications and the expanding healthcare infrastructure catering to urological conditions. Overall, the Laser & Lithotripsy Devices segment experiences rapid growth due to the escalating prevalence of urolithiasis, technological advancements enhancing device efficacy and safety, and the shift towards minimally invasive treatment modalities in urology.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossB. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Boston Scientific Corp, Cardinal Health Inc, Coloplast A/S, ConvaTec Group Plc, Fresenius Medical Care AG & Co. KGaA, Intuitive Surgical Inc, Medtronic plc, Olympus Corp, Stryker Corp, Teleflex Inc
By Product
Instruments
-Dialysis Devices
-Endoscopes
-Laser & Lithotripsy Devices
Consumables & Accessories
-Dialysis Consumables
-Guidewires
-Stents and Implants
-Biopsy Devices
By Application
Kidney failure treatment devices
UI management devices
BPH treatment devices
Urolithiasis treatment devices
Others
By End-User
Hospitals
ASCS
Dialysis Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
B. Braun Melsungen AG
Baxter International Inc
Becton, Dickinson and Company
Boston Scientific Corp
Cardinal Health Inc
Coloplast A/S
ConvaTec Group Plc
Fresenius Medical Care AG & Co. KGaA
Intuitive Surgical Inc
Medtronic plc
Olympus Corp
Stryker Corp
Teleflex Inc
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Urology Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Urology Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Urology Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Urology Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Urology Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Urology Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Urology Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Urology Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Urology Devices Industry
4.2 Key Market Trends in Urology Devices Industry
4.3 Potential Opportunities in Urology Devices Industry
4.4 Key Challenges in Urology Devices Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Urology Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Urology Devices Market Outlook by Segments
7.1 Urology Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Instruments
-Dialysis Devices
-Endoscopes
-Laser & Lithotripsy Devices
Consumables & Accessories
-Dialysis Consumables
-Guidewires
-Stents and Implants
-Biopsy Devices
By Application
Kidney failure treatment devices
UI management devices
BPH treatment devices
Urolithiasis treatment devices
Others
By End-User
Hospitals
ASCS
Dialysis Centers
Others
8 North America Urology Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Urology Devices Markets in 2024
8.2 North America Urology Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Urology Devices Market size Outlook by Segments, 2021-2030
By Product
Instruments
-Dialysis Devices
-Endoscopes
-Laser & Lithotripsy Devices
Consumables & Accessories
-Dialysis Consumables
-Guidewires
-Stents and Implants
-Biopsy Devices
By Application
Kidney failure treatment devices
UI management devices
BPH treatment devices
Urolithiasis treatment devices
Others
By End-User
Hospitals
ASCS
Dialysis Centers
Others
9 Europe Urology Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Urology Devices Markets in 2024
9.2 Europe Urology Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Urology Devices Market Size Outlook by Segments, 2021-2030
By Product
Instruments
-Dialysis Devices
-Endoscopes
-Laser & Lithotripsy Devices
Consumables & Accessories
-Dialysis Consumables
-Guidewires
-Stents and Implants
-Biopsy Devices
By Application
Kidney failure treatment devices
UI management devices
BPH treatment devices
Urolithiasis treatment devices
Others
By End-User
Hospitals
ASCS
Dialysis Centers
Others
10 Asia Pacific Urology Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Urology Devices Markets in 2024
10.2 Asia Pacific Urology Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Urology Devices Market size Outlook by Segments, 2021-2030
By Product
Instruments
-Dialysis Devices
-Endoscopes
-Laser & Lithotripsy Devices
Consumables & Accessories
-Dialysis Consumables
-Guidewires
-Stents and Implants
-Biopsy Devices
By Application
Kidney failure treatment devices
UI management devices
BPH treatment devices
Urolithiasis treatment devices
Others
By End-User
Hospitals
ASCS
Dialysis Centers
Others
11 South America Urology Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Urology Devices Markets in 2024
11.2 South America Urology Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Urology Devices Market size Outlook by Segments, 2021-2030
By Product
Instruments
-Dialysis Devices
-Endoscopes
-Laser & Lithotripsy Devices
Consumables & Accessories
-Dialysis Consumables
-Guidewires
-Stents and Implants
-Biopsy Devices
By Application
Kidney failure treatment devices
UI management devices
BPH treatment devices
Urolithiasis treatment devices
Others
By End-User
Hospitals
ASCS
Dialysis Centers
Others
12 Middle East and Africa Urology Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Urology Devices Markets in 2024
12.2 Middle East and Africa Urology Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Urology Devices Market size Outlook by Segments, 2021-2030
By Product
Instruments
-Dialysis Devices
-Endoscopes
-Laser & Lithotripsy Devices
Consumables & Accessories
-Dialysis Consumables
-Guidewires
-Stents and Implants
-Biopsy Devices
By Application
Kidney failure treatment devices
UI management devices
BPH treatment devices
Urolithiasis treatment devices
Others
By End-User
Hospitals
ASCS
Dialysis Centers
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
B. Braun Melsungen AG
Baxter International Inc
Becton, Dickinson and Company
Boston Scientific Corp
Cardinal Health Inc
Coloplast A/S
ConvaTec Group Plc
Fresenius Medical Care AG & Co. KGaA
Intuitive Surgical Inc
Medtronic plc
Olympus Corp
Stryker Corp
Teleflex Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Instruments
-Dialysis Devices
-Endoscopes
-Laser & Lithotripsy Devices
Consumables & Accessories
-Dialysis Consumables
-Guidewires
-Stents and Implants
-Biopsy Devices
By Application
Kidney failure treatment devices
UI management devices
BPH treatment devices
Urolithiasis treatment devices
Others
By End-User
Hospitals
ASCS
Dialysis Centers
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Urology Devices Market is one of the lucrative growth markets, poised to register a 7.8% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Boston Scientific Corp, Cardinal Health Inc, Coloplast A/S, ConvaTec Group Plc, Fresenius Medical Care AG & Co. KGaA, Intuitive Surgical Inc, Medtronic plc, Olympus Corp, Stryker Corp, Teleflex Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume